Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 11 November 1988:
Vol. 242. no. 4880, pp. 933 - 935
DOI: 10.1126/science.3263702
Prev | Table of Contents | Next

Articles

Science, Vol 242, Issue 4880, 933-935
Copyright © 1988 by American Association for the Advancement of Science

articles

Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors

P Yaish, A Gazit, C Gilon, and A Levitzki

Department of Biological Chemistry, Hebrew University of Jerusalem, Israel.

A systematic series of low molecular weight protein tyrosine kinase inhibitors were synthesized; they had progressively increasing affinity over a 2500-fold range toward the substrate site of epidermal growth factor (EGF) receptor kinase domain. These compounds inhibited EGF receptor kinase activity up to three orders of magnitude more than they inhibited insulin receptor kinase, and they also effectively inhibited the EGF-dependent autophosphorylation of the receptor. The most potent compounds effectively inhibited the EGF-dependent proliferation of A431/clone 15 cells with little or no effect on the EGF-independent proliferation of these cells. The potential use of tyrosine protein kinase inhibitors as antiproliferative agents is demonstrated.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Translation of the Philadelphia chromosome into therapy for CML.
B. J. Druker (2008)
Blood 112, 4808-4817
   Abstract »    Full Text »    PDF »
A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators.
P. Stoilov, C.-H. Lin, R. Damoiseaux, J. Nikolic, and D. L. Black (2008)
PNAS 105, 11218-11223
   Abstract »    Full Text »    PDF »
Brain-derived neurotrophic factor enhances the excitability of rat sensory neurons through activation of the p75 neurotrophin receptor and the sphingomyelin pathway.
Y. H. Zhang, X. X. Chi, and G. D. Nicol (2008)
J. Physiol. 586, 3113-3127
   Abstract »    Full Text »    PDF »
Requirement of hypoxia-inducible factor-1{alpha} down-regulation in mediating the antitumor activity of the anti-epidermal growth factor receptor monoclonal antibody cetuximab.
X. Li, Y. Lu, K. Liang, T. Pan, J. Mendelsohn, and Z. Fan (2008)
Mol. Cancer Ther. 7, 1207-1217
   Abstract »    Full Text »    PDF »
Pyruvate Dehydrogenase Complex Deficiency Caused by Ubiquitination and Proteasome-mediated Degradation of the E1 Subunit.
Z. Han, L. Zhong, A. Srivastava, and P. W. Stacpoole (2008)
J. Biol. Chem. 283, 237-243
   Abstract »    Full Text »    PDF »
Tyrphostin A8 stimulates a novel trafficking pathway of apically endocytosed transferrin through Rab11-enriched compartments in Caco-2 cells.
F. Norouziyan, W.-C. Shen, and S. F. Hamm-Alvarez (2008)
Am J Physiol Cell Physiol 294, C7-C21
   Abstract »    Full Text »    PDF »
PTEN-Mediated Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors.
I. K. Mellinghoff, T. F. Cloughesy, and P. S. Mischel (2007)
Clin. Cancer Res. 13, 378-381
   Abstract »    Full Text »    PDF »
Chronic myeloid leukemia: Standard treatment options..
D. Frame (2006)
Am. J. Health Syst. Pharm. 63, S10-S14
   Abstract »    Full Text »    PDF »
Tumor Endothelial Cells Express Epidermal Growth Factor Receptor (EGFR) but not ErbB3 and Are Responsive to EGF and to EGFR Kinase Inhibitors.
D. N. Amin, K. Hida, D. R. Bielenberg, and M. Klagsbrun (2006)
Cancer Res. 66, 2173-2180
   Abstract »    Full Text »    PDF »
Insulin Receptor Substrate Is a Mediator of Phosphoinositide 3-Kinase Activation in Quiescent Pancreatic Cancer Cells.
T. Asano, Y. Yao, S. Shin, J. McCubrey, J. L. Abbruzzese, and S. A.G. Reddy (2005)
Cancer Res. 65, 9164-9168
   Abstract »    Full Text »    PDF »
Enhanced Efficacy of Radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling with EGFR Tyrosine Kinase Inhibitor AG1478.
F. T. Lee, A. J. Mountain, M. P. Kelly, C. Hall, A. Rigopoulos, T. G. Johns, F. E. Smyth, M. W. Brechbiel, E. C. Nice, A. W. Burgess, et al. (2005)
Clin. Cancer Res. 11, 7080s-7086s
   Abstract »    Full Text »    PDF »
PDGF receptor kinase inhibitors for the treatment of restenosis.
A. Levitzki (2005)
Cardiovasc Res 65, 581-586
   Abstract »    Full Text »    PDF »
Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.
T. G. Johns, R. B. Luwor, C. Murone, F. Walker, J. Weinstock, A. A. Vitali, R. M. Perera, A. A. Jungbluth, E. Stockert, L. J. Old, et al. (2003)
PNAS 100, 15871-15876
   Abstract »    Full Text »    PDF »
Tyrphostin A23 Inhibits Internalization of the Transferrin Receptor by Perturbing the Interaction between Tyrosine Motifs and the Medium Chain Subunit of the AP-2 Adaptor Complex.
D. N. Banbury, J. D. Oakley, R. B. Sessions, and G. Banting (2003)
J. Biol. Chem. 278, 12022-12028
   Abstract »    Full Text »    PDF »
Protein kinase antagonists inhibit invasion of mammalian cells by Fonsecaea pedrosoi.
C. L. Limongi, W. De Souza, and S. Rozental (2003)
J. Med. Microbiol. 52, 201-209
   Abstract »    Full Text »    PDF »
Risk and the Efficacy of Antiinflammatory Agents: Retrospective and Confirmatory Studies of Sepsis.
P. Q. Eichacker, C. Parent, A. Kalil, C. Esposito, X. Cui, S. M. Banks, E. P. Gerstenberger, Y. Fitz, R. L. Danner, and C. Natanson (2002)
Am. J. Respir. Crit. Care Med. 166, 1197-1205
   Abstract »    Full Text »    PDF »
ZD1839 (Iressa): An Orally Active Inhibitor of Epidermal Growth Factor Signaling with Potential for Cancer Therapy.
A. E. Wakeling, S. P. Guy, J. R. Woodburn, S. E. Ashton, B. J. Curry, A. J. Barker, and K. H. Gibson (2002)
Cancer Res. 62, 5749-5754
   Abstract »    Full Text »    PDF »
Tyrphostins Protect Neuronal Cells from Oxidative Stress.
Y. Sagara, K. Ishige, C. Tsai, and P. Maher (2002)
J. Biol. Chem. 277, 36204-36215
   Abstract »    Full Text »    PDF »
Regulation of Steroidogenic Genes by Insulin-Like Growth Factor-1 and Follicle-Stimulating Hormone: Differential Responses of Cytochrome P450 Side-Chain Cleavage, Steroidogenic Acute Regulatory Protein, and 3{beta}-Hydroxysteroid Dehydrogenase/Isomerase in Rat Granulosa Cells.
S. Eimerl and J. Orly (2002)
Biol Reprod 67, 900-910
   Abstract »    Full Text »    PDF »
Cell Surface Antigen and Molecular Targeting in the Treatment of Hematologic Malignancies.
A. Countouriotis, T. B. Moore, and K. M. Sakamoto (2002)
Stem Cells 20, 215-229
   Abstract »    Full Text »    PDF »
Imatinib Mesylate -- A New Oral Targeted Therapy.
D. G. Savage and K. H. Antman (2002)
N. Engl. J. Med. 346, 683-693
   Full Text »    PDF »
The Kinase Inhibitor PP1 Blocks Tumorigenesis Induced by RET Oncogenes.
F. Carlomagno, D. Vitagliano, T. Guida, M. Napolitano, G. Vecchio, A. Fusco, A. Gazit, A. Levitzki, and M. Santoro (2002)
Cancer Res. 62, 1077-1082
   Abstract »    Full Text »    PDF »
STI571: A Paradigm of New Agents for Cancer Therapeutics.
M. J. Mauro, M. O'Dwyer, M. C. Heinrich, and B. J. Druker (2002)
J. Clin. Oncol. 20, 325-334
   Abstract »    Full Text »    PDF »
Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity.
O. Bartsch, B. Bartlick, and R. Ivell (2001)
Mol. Hum. Reprod. 7, 799-809
   Abstract »    Full Text »    PDF »
STI571: Targeting BCR-ABL as Therapy for CML.
M. J. Mauro and B. J. Druker (2001)
Oncologist 6, 233-238
   Abstract »    Full Text »    PDF »
Design of a Chimeric 3-Methyl-1,2,3-triazene with Mixed Receptor Tyrosine Kinase and DNA Damaging Properties: A Novel Tumor Targeting Strategy.
S. L. Matheson, J. McNamee, and B. J. Jean-Claude (2001)
J. Pharmacol. Exp. Ther. 296, 832-840
   Abstract »    Full Text »
Clastogenic effects of two tyrosine kinase inhibitors, Tyrphostin 23 and Tyrphostin 46, on a transformed (CHO-K1) and on a primary embryonic Chinese hamster cell line (CHE).
L. Bassi, R. Buzzi, M. Fiore, and F. Palitti (2000)
Mutagenesis 15, 341-347
   Abstract »    Full Text »    PDF »
The Tyrosine Kinase Inhibitor Tyrphostin AG126 Reduces the Development of Acute and Chronic Inflammation.
S. Cuzzocrea, M. C. McDonald, E. Mazzon, D. Siriwardena, G. Calabro, D. Britti, G. Mazzullo, A. De Sarro, A. P. Caputi, and C. Thiemermann (2000)
Am. J. Pathol. 157, 145-158
   Abstract »    Full Text »    PDF »
The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach.
R. E. Favoni and A. De Cupis (2000)
Pharmacol. Rev. 52, 179-206
   Abstract »    Full Text »    PDF »
Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines.
E. Weisberg and J. D. Griffin (2000)
Blood 95, 3498-3505
   Abstract »    Full Text »    PDF »
Activation of Epidermal Growth Factor Receptor during Corneal Epithelial Migration.
J. D. Zieske, H. Takahashi, A. E. K. Hutcheon, and A. C. Dalbone (2000)
Invest. Ophthalmol. Vis. Sci. 41, 1346-1355
   Abstract »    Full Text »
Hypoxia Induces Transcription of the Plasminogen Activator Inhibitor-1 Gene Through Genistein-Sensitive Tyrosine Kinase Pathways in Vascular Endothelial Cells.
T. Uchiyama, M. Kurabayashi, Y. Ohyama, T. Utsugi, N. Akuzawa, M. Sato, S. Tomono, S. Kawazu, and R. Nagai (2000)
Arterioscler. Thromb. Vasc. Biol. 20, 1155-1161
   Abstract »    Full Text »    PDF »
Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies.
H. Kantarjian, J. V. Melo, S. Tura, S. Giralt, and M. Talpaz (2000)
Hematology 2000, 90-109
   Abstract »    Full Text »    PDF »
Tyrosine Phosphorylation Regulates Rapid Endocytosis in Adrenal Chromaffin Cells.
P. G. P. Nucifora and A. P. Fox (1999)
J. Neurosci. 19, 9739-9746
   Abstract »    Full Text »    PDF »
Mitotic aberrations induced by carbaryl reflect tyrosine kinase inhibition with coincident up-regulation of serine/threonine protein phosphatase activity: implications for coordination of karyokinesis and cytokinesis.
A. Renglin, A.-S. Harmala-Brasken, J. E. Eriksson, and A. Onfelt (1999)
Mutagenesis 14, 327-333
   Abstract »    Full Text »    PDF »
Adeno-Associated Virus Type 2-Mediated Gene Transfer: Role of Epidermal Growth Factor Receptor Protein Tyrosine Kinase in Transgene Expression.
C. Mah, K. Qing, B. Khuntirat, S. Ponnazhagan, X.-S. Wang, D. M. Kube, M. C. Yoder, and A. Srivastava (1998)
J. Virol. 72, 9835-9843
   Abstract »    Full Text »    PDF »
Expression of Thrombomodulin in Atherosclerotic Lesions and Mitogenic Activity of Recombinant Thrombomodulin in Vascular Smooth Muscle Cells.
G. Tohda, K. Oida, Y. Okada, S. Kosaka, E. Okada, S. Takahashi, H. Ishii, and I. Miyamori (1998)
Arterioscler. Thromb. Vasc. Biol. 18, 1861-1869
   Abstract »    Full Text »    PDF »
Inhibition of the Interaction between Tyrosine-based Motifs and the Medium Chain Subunit of the AP-2 Adaptor Complex by Specific Tyrphostins.
C. M. Crump, J. L. Williams, D. J. Stephens, and G. Banting (1998)
J. Biol. Chem. 273, 28073-28077
   Abstract »    Full Text »    PDF »
Epidermal Growth Factor (EGF) Modulates Fetal Thymocyte Growth and Differentiation: Partial Reversal by Insulin, Mimicking by Specific Inhibitors of EGF Receptor Tyrosine Kinase Activity, and Differential Expression of CD45 Phosphatase Isotypes.
C. S. Freitas, S. R. Dalmau, and W. Savino (1998)
J. Immunol. 161, 3384-3392
   Abstract »    Full Text »    PDF »
A Model for Signal Transduction during Gamete Release in the Fucoid Alga Pelvetia compressa.
G. Anthony Pearson and S. Howard Brawley (1998)
Plant Physiology 118, 305-313
   Abstract »    Full Text »
Signal Transduction during Legionella pneumophila Entry into Human Monocytes.
P. Y. Coxon, J. T. Summersgill, J. A. Ramirez, and R. D. Miller (1998)
Infect. Immun. 66, 2905-2913
   Abstract »    Full Text »    PDF »
Involvement of C-Abl Tyrosine Kinase in Lipopolysaccharide- Induced Macrophage Activation.
Q. Le, R. Daniel, S.-W. Chung, A. D. Kang, T. K. Eisenstein, B. M. Sultzer, H. Simpkins, and P. M. C. Wong (1998)
J. Immunol. 160, 3330-3336
   Abstract »    Full Text »    PDF »
Regulation of vascular angiotensin II receptors by EGF.
M. E. Ullian, J. R. Raymond, M. C. Willingham, and R. V. Paul (1997)
Am J Physiol Cell Physiol 273, C1241-C1249
   Abstract »    Full Text »    PDF »
Specific Inhibition of Insulin-Like Growth Factor-1 and Insulin Receptor Tyrosine Kinase Activity and Biological Function by Tyrphostins.
M. Parrizas, A. Gazit, A. Levitzki, E. Wertheimer, and D. LeRoith (1997)
Endocrinology 138, 1427-1433
   Abstract »    Full Text »    PDF »
Hyaluronan Synthesis by Mouse Cumulus Cells Is Regulated by Interactions between Follicle-stimulating Hormone (or Epidermal Growth Factor) and a Soluble Oocyte Factor (or Transforming Growth Factor beta 1).
E. Tirone, C. D'Alessandris, V. C. Hascall, G. Siracusa, and A. Salustri (1997)
J. Biol. Chem. 272, 4787-4794
   Abstract »    Full Text »    PDF »
Hypothalamic Astrocytes Respond to Transforming Growth Factor-{alpha} with the Secretion of Neuroactive Substances That Stimulate the Release of Luteinizing Hormone-Releasing Hormone.
Y. J. Ma, K. Berg-von der Emde, F. Rage, W. C. Wetsel, and S. R. Ojeda (1997)
Endocrinology 138, 19-25
   Abstract »    Full Text »    PDF »
Differential Activation of Mitogen-activated Protein Kinase and S6 Kinase Signaling Pathways by 12-O-Tetradecanoylphorbol-13-acetate (TPA) and Insulin.
R. Seger, Y. Biener, R. Feinstein, T. Hanoch, A. Gazit, and Y. Zick (1995)
J. Biol. Chem. 270, 28325-28330
   Abstract »    Full Text »    PDF »
Phosphotyrosine-Dependent Targeting of Mitogen-Activated Protein Kinase in Differentiated Contractile Vascular Cells.
R. A. Khalil, C. B. Menice, C.-L. A. Wang, and K. G. Morgan (1995)
Circ. Res. 76, 1101-1108
   Abstract »    Full Text »
Inhibition of Autophagy and Multiple Steps in Asialoglycoprotein Endocytosis by Inhibitors of Tyrosine Protein Kinases (Tyrphostins).
I. Holen, P. E. Str, P. B. Gordon, M. Fengsrud, T. O. Berg, and P. O. Seglen (1995)
J. Biol. Chem. 270, 12823-12831
   Abstract »    Full Text »    PDF »
Tyrosine kinase inhibition: an approach to drug development.
A Levitzki and A Gazit (1995)
Science 267, 1782-1788
   Abstract »    PDF »
Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors.
A Novogrodsky, A Vanichkin, M Patya, A Gazit, N Osherov, and A Levitzki (1994)
Science 264, 1319-1322
   Abstract »    PDF »
EGF abrogation-induced fusilli-form dysmorphogenesis of Meckel's cartilage during embryonic mouse mandibular morphogenesis in vitro.
L Shum, Y Sakakura, P Bringas, W Luo, M. Snead, M Mayo, C Crohin, S Millar, Z Werb, S Buckley, et al. (1993)
Development 118, 903-917
   Abstract »    PDF »
Growth factors and cancer.
S. Aaronson (1991)
Science 254, 1146-1153
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)